Page 64 - Read Online
P. 64

Ditonno et al. Mini-invasive Surg 2023;7:36  https://dx.doi.org/10.20517/2574-1225.2023.62  Page 9 of 10

               CONCLUSION
               SP RAPN is rapidly emerging as a novel and promising approach for the treatment of small renal masses.
               Initial comparative studies suggest that SP RAPN can offer similar peri- and post-operative outcomes
               compared to MP RAPN, with potential benefits such as lower opioid use and improved cosmetic results.
               One of the main features of this novel technology is that it allows the expansion of the role of
               retroperitoneal kidney surgery. This can translate into faster post-operative recovery, which could
               ultimately lead to the implementation of outpatient surgery. To date, SP RAPN has been used mostly for
               low to intermediate complexity tumors, but maturing experience will extend its indications to more
               complex cases. Further research is warranted to corroborate early promising studies and better define the
               role of SP RAPN.


               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to the conception and design of the work: Ditonno F, Franco A, Autorino R
               Drafted the manuscript: Ditonno F
               Performed data analysis and interpretation: Autorino R, Ditonno F, Manfredi C
               Critically revised the work: Autorino R, Antonelli A, De Nunzio C, De Sio M


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2023.

               REFERENCES
               1.       Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of urology guidelines on renal cell carcinoma: the 2022 update.
                   Eur Urol 2022;82:399-410.  DOI
               2.       Falagario U, Veccia A, Weprin S, et al. Robotic-assisted surgery for the treatment of urologic cancers: recent advances. Expert Rev
                   Med Devices 2020;17:579-90.  DOI
               3.       Kaouk JH, Haber GP, Autorino R, et al. A novel robotic system for single-port urologic surgery: first clinical investigation. Eur Urol
                   2014;66:1033-43.  DOI
               4.       Dobbs RW, Halgrimson WR, Talamini S, Vigneswaran HT, Wilson JO, Crivellaro S. Single-port robotic surgery: the next generation
                   of minimally invasive urology. World J Urol 2020;38:897-905.  DOI  PubMed
               5.       Lai A, Chen GL, di Meo NA, Crivellaro S. Single-port robotic surgery: general principles and troubleshooting. J Endourol
                   2022;36:S25-8.  DOI  PubMed
               6.       Kaouk J, Garisto J, Eltemamy M, Bertolo R. Pure single-site robot-assisted partial nephrectomy using the SP surgical system: initial
                   clinical experience. Urology 2019;124:282-5.  DOI  PubMed
               7.       Vazquez-Martul D, Iglesias-Alvarado J, Altez-Fernandez C, Chantada-Abal V. Single-port retroperitoneoscopic partial nephrectomy:
   59   60   61   62   63   64   65   66   67   68   69